Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

Near A. M., et al. Progesterone Receptor Gene Polymorphisms and Risk of Endometriosis: Results from an International Collaborative Effort. Fertil. Steril., 2011; 95 (1):40–45.

Nedrow A., et al. Complementary and alternative therapies for the management of menopause-related symptoms. Arch. Intern. Med., 2006; 166 (14):1453–1465.

Nelson M. M., Forfar J. O. Epidemiology of drug taken by pregnant women: drugs that may affect the fetus adversely. Clin. Pharmacol., 1971; 14:632–642.

Neulen J., Breckwoldt M. Placental progesterone, prostaglandins and mechanisms leading to initiation of parturition in the human. Exp. Clin. Endocrinol., 1994; 102:195–202.

Nillius S. J., Johansson E. D. B. Plasma progesterone levels after intramuscular or rectal administration of progesterone. Acta Obstet. Gynecol. Scand., 1971; 50:46.

Nillni Y. I., et al. Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Rohan Clin. Psychol. Rev., 2011 November; 31 (7):1183–1191.

Niswender G. D., et al. Judge, jury and executioner: the auto-regulation of luteal function. Soc. Reprod. Fertil. Suppl., 2007; 64:191–206.

Niswender G. D., et al. Mechanisms controlling the function and life span of the corpus luteum. Physiol. Rev., 2000; 80 (1):1–29.

Niswender G. D. Molecular control of luteal secretion of progesterone. Reproduction, 2002; 123:333–339.

Niu Z., et al. Progesterone levels on oocyte retrieval day can predict the quantity of viable embryos but not pregnancy outcome of intracytoplasmic sperm injection. Gynecol. Endocrinol., 2008; 24 (8):452–458.

Nora A. H., Nora J. J. A syndrome of multiple congenital anomalies associated with teratogenic exposure. Arch. Environ. Health, 1975; 30:17–21.

North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause, 2010; 17:242–255.

Northen A. T., et al. National Institute of Child Health and Human Development (NICHD). Maternal-Fetal Medicine Units (MFMU). Network: follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo. Obstet. Gynecol., 2007; 110:865–872.

Norwitz E. R., Caughey A. B. Progesterone Supplementation and the Prevention of Preterm Birth. Rev. Obstet. Gynecol., 2011; 4 (2):60–72.

Norwitz E. R., Schust D. J., Fisher S. J. Implantation and the survival of early pregnancy. N. Engl. J. Med., 2001; 345:1400–1408.

Nosarka S., Kruger T., Siebert I., Grové D. Luteal phase support in in vitro fertilization: meta-analysis of randomized trials. Gynecol. Obstet. Invest., 2005; 60:67–74.

Novak E. An Appraisal of Ovarian Therapy. Endocrinology, 1922; 6:599.

Nowak R. A. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors. Environ Health Perspect, 2000; 108 Suppl 5:849–853.

Ntrivalas E. I., et al. Status of peripheral blood natural killer cells in women with recurrent spontaneous abortions and infertility of unknown aetiology. Hum. Reprod., 2001; 16:855–861.

Numan M. Progesterone inhibition of maternal behavior in the rat. Horm. Behav., 1978; 11:209–231.

Nyboe Andersen A., et al. Progesterone supplementation during early gestation after IVF or ICSI has no effect on the delivery rates: a randomized controlled trial. Hum. Reprod 2002; 17:357–361.

O’Brien J. M., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet. Gynecol., 2007; 30:687–696.

Oates-Whitehead R. M., Haas D. M., Carrier J. A. K. Progestogen for preventing miscarriage. Cochrane Database Syst. Rev., 2003; 4:CD003511.

Oehninger S., et al. A sequential analysis of the effect of progesterone on specific sperm functions crucial to fertilization in vitro in infertile patients. Hum. Reprod., 1994; 9:1322–1327.

Office of Environmental Health Hazard Assessment (OEHHA). Evidence for Developmental and Reproductive Toxicity of Progesterone. 2004. Available at http://www.oehha.org/prop65/hazard_ident/pdf_zip/progeshid5.pdf.

Ogihara T., Matsumoto S., Ohnishi S. Functional characterization of active transport of progesterone to adrenal cells. JPP, 2004; 56:79–84.

Ojeda S. R. Female Reproductive Function. In Text Book Endocrine Physiology. Edited by: Graffin J. E. and Ojeda S.R. Oxford, New York: Oxford University Press; 5 2004:186–225.

Okada A., et al. Ef fect of estrogens on ontogenetic expression of progesterone receptor in the fetal female rat reproductive tract. Mol. Cell. Endocrinol., 2002; 195:55–64.

Omar M. H., et al. Dydrogesterone in threatened abortion: pregnancy outcome. J. Steroid. Biochem. Mol. Biol., 2005; 97:421–425.

O’Neill T. Progesterone prophylaxis? BJP, 1990; 157:776–777.

Oren-Benaroya R., et al. The sperm chemoattractant secreted from human cumulus cells is progesterone. Hum. Reprod., 2008; 23:2339–2345.